Search Results - "Jeong-ok Lee"

Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer by Kim, Jin Won, Nam, Kyung Han, Ahn, Sang-Hoon, Park, Do Joong, Kim, Hyung-Ho, Kim, Se Hyun, Chang, Hyun, Lee, Jeong-Ok, Kim, Yu Jung, Lee, Hye Seung, Kim, Jee Hyun, Bang, Soo-Mee, Lee, Jong Seok, Lee, Keun-Wook

“…Background There are few data on the clinical implications of immunosuppressive protein expression in tumors and immune cell infiltration within the tumor…”
Get full text

Phase II trial of posaconazole prophylaxis during anti‐thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome by Kim, Dong Hyun, Hong, Junshik, Shin, Dong‐Yeop, Kim, Inho, Yoon, Sung‐Soo, Bang, Soo Mee, Lee, Jeong‐Ok, Lee, Ji Yun, Kim, Sang‐A, Byun, Ja Min, Koh, Youngil

Get full text

Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma by Kwon, Hyun Jung, Yang, Jeong Mi, Lee, Jeong-Ok, Lee, Jong Seok, Paik, Jin Ho

“…Antitumor immune response of programmed cell death ligand (PD-L1) has shown clinical value not only in Hodgkin lymphoma and EBV-associated lymphomas but also…”
Get full text

Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study by Yhim, Ho-Young, Lee, Juhyun, Lee, Ji Yun, Lee, Jeong-Ok, Bang, Soo-Mee

“…Limited data is available regarding the pharmacological prophylaxis for venous thromboembolism (VTE) in Asian patients undergoing total knee arthroplasty or…”
Get full text

Apixaban for the treatment of acute splanchnic vein thrombosis: A pilot study by Kim, Sang-A, Choi, Gwang Hyeon, Lee, Ji Yun, Jang, Eun Sun, Lee, Jeong-Ok, Kim, Jin-Wook, Jeong, Sook-Hyang, Bang, Soo-Mee

“…•Direct oral anticoagulants lack data for splanchnic vein thrombosis (SVT).•This study explores the role of apixaban in SVT.•This study enrolled 23 patients…”
Get full text

Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study by Kang, Minsu, Suh, Koung Jin, Kim, Ji-Won, Byun, Ja Min, Kim, Jin Won, Lee, Ji Yun, Lee, Jeong-Ok, Bang, Soo-Mee, Kim, Yu Jung, Kim, Se Hyun, Kim, Jee Hyun, Lee, Jong Seok, Lee, Keun-Wook

“…Splanchnic vein thrombosis (SpVT) in solid tumors has not been well investigated. Therefore, the treatment guidelines for SpVT are not well established. We…”
Get full text

Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli by Lee, Eun-Young, Bang, Joo Young, Park, Gun Wook, Choi, Dong-Sic, Kang, Ji Seoun, Kim, Hyun-Jung, Park, Kyong-Su, Lee, Jeong-Ok, Kim, Yoon-Keun, Kwon, Kyung-Hoon, Kim, Kwang-Pyo, Gho, Yong Song

“…Gram‐negative bacteria constitutively secrete native outer membrane vesicles (OMVs) into the extracellular milieu. Although recent progress in this area has…”
Get full text

Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy by Park, Hyunkyung, Youk, Jeonghwan, Shin, Dong-Yeop, Hong, Junshik, Kim, Inho, Kim, Nam Joong, Lee, Jeong-Ok, Bang, Soo-Mee, Yoon, Sung-Soo, Park, Wan Beom, Koh, Youngil

“…Micafungin is a well-tolerated and effective prophylactic antifungal agent used in hematologic diseases. In this prospective trial, we evaluated the efficacy…”
Get full text

A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas by Kim, Miso, Lee, Jeong-Ok, Koh, Jiwon, Kim, Tae Min, Lee, Ji Yun, Jeon, Yoon Kyung, Keam, Bhumsuk, Kim, Dong-Wan, Lee, Jong Seok, Heo, Dae Seog

Get full text

PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer by Kim, Kui-Jin, Kim, Ji-Won, Sung, Ji Hea, Suh, Koung Jin, Lee, Ji Yun, Kim, Se Hyun, Lee, Jeong-Ok, Kim, Jin Won, Kim, Yu Jung, Kim, Jee Hyun, Bang, Soo-Mee, Lee, Jong Seok, Kim, Hark Kyun, Lee, Keun-Wook

“…PIK3CA mutations are frequently observed in various human cancers including gastric cancer (GC). This study was conducted to investigate the anti-tumor effects…”
Get full text

Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer by Kim, Sang-A, Park, Hyejoo, Kim, Kui-Jin, Kim, Ji-Won, Sung, Ji Hea, Nam, Milang, Lee, Ju Hyun, Jung, Eun Hee, Suh, Koung Jin, Lee, Ji Yun, Kim, Se Hyun, Lee, Jeong-Ok, Kim, Jin Won, Kim, Yu Jung, Kim, Jee Hyun, Bang, Soo-Mee, Lee, Jong Seok, Lee, Keun-Wook

“…Amphiregulin (AREG) is an epidermal growth factor receptor (EGFR) ligand. The aim of this study was to investigate the effects of baseline plasma AREG levels…”
Get full text

Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer by Keam, Bhumsuk, Kim, Dong-Wan, Park, Jin Hyun, Lee, Jeong-Ok, Kim, Tae Min, Lee, Se-Hoon, Chung, Doo Hyun, Heo, Dae Seog

“…Background There are many complex and rare mutations in the epidermal growth factor receptor ( EGFR ) gene in non-small cell lung cancer (NSCLC) other than the…”
Get full text

Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial by Park, Changhee, Lee, Ho Sup, Kang, Ka-Won, Lee, Won-Sik, Do, Young Rok, Kwak, Jae-Yong, Shin, Ho-Jin, Kim, Sung-Yong, Yi, Jun Ho, Lim, Sung-Nam, Lee, Jeong-Ok, Yang, Deok-Hwan, Jang, Hun, Choi, Byoungsan, Lim, Jiwoo, Sun, Choong Hyun, Byun, Ja Min, Yoon, Sung-Soo, Koh, Youngil

“…Potential synergism between Bruton’s tyrosine kinase (BTK) inhibitor and lenalidomide in treating aggressive B-cell lymphoma has been suggested. Here, the…”
Get full text

Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms by Choi, Hyoung Soo, Hong, Junshik, Hwang, Sang Mee, Lee, Ju Hyun, Ma, Youngeun, Kim, Sang-A, Lee, Ji Yun, Lee, Jeong-Ok, Bang, Soo-Mee

“…Myeloproliferative neoplasms are rare at a young age, and few reports have described the disease characteristics and outcomes in this group. This study aimed…”
Get full text

Chemotherapy delivery time affects treatment outcomes of female patients with diffuse large B cell lymphoma by Kim, Dae Wook, Byun, Ja Min, Lee, Jeong-Ok, Kim, Jae Kyoung, Koh, Youngil

“…BACKGROUNDChronotherapy is a drug intervention at specific times of the day to optimize efficacy and minimize adverse effects. Its value in hematologic…”
Get full text

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer by Kim, Mi-Jung, Lee, Hye Seung, Kim, Jee Hyun, Kim, Yu Jung, Kwon, Ji Hyun, Lee, Jeong-Ok, Bang, Soo-Mee, Park, Kyoung Un, Kim, Duck-Woo, Kang, Sung-Bum, Kim, Jae-Sung, Lee, Jong Seok, Lee, Keun-Wook

“…We evaluated the association between a KRAS mutational status and various clinicopathologic features including the metastatic pattern in patients with…”
Get full text

Pneumocystis jirovecii pneumonia in diffuse large B‐cell Lymphoma treated with R‐CHOP by Lee, Ji Yun, Kang, Minsu, Suh, Koung Jin, Kim, Ji‐Won, Kim, Se Hyun, Kim, Jin Won, Kim, Yu Jung, Song, Kyoung‐Ho, Kim, Eu Suk, Kim, Hong Bin, Lee, Keun‐Wook, Kim, Jee Hyun, Bang, Soo‐Mee, Lee, Jong‐Seok, Lee, Jeong‐Ok

“…Background The aim of this study was to estimate the incidence of and risk factors for Pneumocystis pneumonia (PCP) infection in diffuse large B‐cell lymphoma…”
Get full text

Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study by Choi, In Sil, Choi, Mihong, Lee, Ju Hyun, Kim, Jee Hyun, Suh, Koung Jin, Lee, Ji Yun, Kang, Beodeul, Kim, Ji-Won, Kim, Se-Hyun, Kim, Jin Won, Lee, Jeong-Ok, Kim, Yu Jung, Bang, Soo-Mee, Lee, Jong Seok, Lee, Keun-Wook

“…There is limited data on third-line chemotherapy in patients with metastatic gastric cancer (MGC). This study was conducted to assess third-line treatment…”
Get full text

Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma by Park, Jeayeon, Chung, Sung Won, Lee, Yun Bin, Shin, Hyunjae, Hur, Moon Haeng, Cho, Heejin, Park, Min Kyung, Youk, Jeonghwan, Lee, Ji Yun, Lee, Jeong-Ok, Yu, Su Jong, Kim, Yoon Jun, Yoon, Jung-Hwan, Kim, Tae Min, Lee, Jeong-Hoon

“…Chronic hepatitis B (CHB) is a risk factor for non-Hodgkin lymphoma (NHL). Our recent study suggested that antiviral treatment may reduce the incidence of NHL…”
Get full text

Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma by Song, Moo‐Kon, Chung, Joo‐Seop, Shin, Ho‐Jin, Moon, Joon‐Ho, Lee, Jeong‐Ok, Lee, Ho‐Sup, Lee, Sang‐Min, Lee, Gyeong‐Won, Lee, Su‐Ee, Kim, Seong‐Jang

“…Primary gastrointestinal (PGI) diffuse large B cell lymphoma (DLBCL) is a relatively common disease. Recent studies indicate that measurement of maximum…”
Get full text